{"id":26222,"date":"2025-11-05T14:15:49","date_gmt":"2025-11-05T07:15:49","guid":{"rendered":"https:\/\/nhathuocngocanh.com\/bp\/?p=26222"},"modified":"2025-11-05T14:15:49","modified_gmt":"2025-11-05T07:15:49","slug":"pemetrexed-disodium-heptahydrate","status":"publish","type":"post","link":"https:\/\/nhathuocngocanh.com\/bp\/pemetrexed-disodium-heptahydrate\/","title":{"rendered":"Pemetrexed Disodium Heptahydrate"},"content":{"rendered":"

(Ph. Eur. monograph 2637)<\/em><\/p>\n

C20<\/sub>H19<\/sub>N5<\/sub>Na2<\/sub>O6<\/sub>,7H2<\/sub>O 597.5 357166-29-1<\/p>\n

Action and use<\/strong><\/p>\n

Thymidylate synthetase inhibitor; cytostatic.<\/p>\n

DEFINITION<\/h2>\n

Disodium (2S)-2-[4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzamido]pentanedioate heptahydrate.<\/p>\n

Content<\/h3>\n

97.5 per cent to 102.0 per cent (anhydrous substance).<\/p>\n

CHARACTERS<\/h2>\n

Appearance<\/h3>\n

White or almost white powder.<\/p>\n

Solubility<\/h3>\n

Freely soluble in water, very slightly soluble in anhydrous ethanol, practically insoluble in methylene chloride.<\/p>\n

IDENTIFICATION<\/h2>\n

A. Infrared absorption spectrophotometry (2.2.24).<\/p>\n

Comparison: pemetrexed disodium heptahydrate CRS.<\/p>\n

B. It gives reaction (a) of sodium (2.3.1).<\/p>\n

C. Enantiomeric purity (see Tests).<\/p>\n

D. Water (see Tests).<\/p>\n

TESTS<\/h2>\n

Solution S<\/h3>\n

Dissolve 0.56 g in carbon dioxide-free water R and dilute to 10.0 mL with the same solvent.<\/p>\n

Appearance of solution<\/h3>\n

Solution S is not more opalescent than reference suspension II (2.2.1) and not more intensely coloured than reference solution GY4 or Y4 (2.2.2, Method II).<\/p>\n

pH (2.2.3)<\/h3>\n

7.5 to 8.4 for solution S.<\/p>\n

Enantiomeric purity<\/h3>\n

Liquid chromatography (2.2.29). Prepare the solutions immediately before use or store them at 2-8 \u00b0C for not more than 24 h.<\/p>\n

Solution A: Dissolve 8 g of \u03b2-cyclodextrin R in 900 mL of water for chromatography R. Add 15 mL of triethylamine R then 6 mL of phosphoric acid R and adjust to pH 6.0 with phosphoric acid R. Dilute to 1000 mL with water for chromatography R.<\/p>\n

Test solution: Dissolve 12.0 mg of the substance to be examined in water R and dilute to 50.0 mL with the same solvent.<\/p>\n

Reference solution (a): Dissolve 6 mg of pemetrexed for system suitability CRS (containing impurity E) in water R and dilute to 25 mL with the same solvent.<\/p>\n

Reference solution (b): Dilute 1.0 mL of the test solution to 100.0 mL with water R. Dilute 3.0 mL of this solution to 10.0 mL with water R.<\/p>\n

Column:<\/p>\n

\u2014 size: l = 0.25 m, \u00d8 = 4.6 mm;<\/p>\n

\u2014 stationary phase: end-capped octadecylsilyl silica gel for chromatography R (5 \u03bcm);<\/p>\n

\u2014 temperature: 40 \u00b0C.<\/p>\n

Mobile phase: acetonitrile for chromatography R, solution A (5:95 V\/V).<\/p>\n

Flow rate: 1.0 mL\/min.<\/p>\n

Detection: Spectrophotometer at 230 nm.<\/p>\n

Injection: 50 \u03bcL.<\/p>\n

Run time: 1.5 times the retention time of pemetrexed.<\/p>\n

Relative retention: With reference to pemetrexed (retention time = about 30 min): impurity E = about 0.94.<\/p>\n

System suitability:<\/p>\n

\u2014 symmetry factor: maximum 2.0 for the principal peak in the chromatogram obtained with reference solution (b);<\/p>\n

\u2014 peak-to-valley ratio: minimum 5.0, where Hp = height above the baseline of the peak due to impurity E and Hv = height above the baseline of the lowest point of the curve separating this peak from the peak due to pemetrexed in the chromatogram obtained with reference solution (a).<\/p>\n

Calculation of percentage content:<\/p>\n

\u2014 for impurity E, use the concentration of pemetrexed disodium heptahydrate in reference solution (b).<\/p>\n

Limit:<\/p>\n

\u2014 impurity E: maximum 0.3 per cent.<\/p>\n

Column rinse: the following program is given for information only.<\/p>\n

Use a gradient column rinse before column storage or after 30 sample injections to avoid build-up on the column. If a drifting baseline is observed, allow additional time for equilibration with the mobile phase. If a blank chromatogram exhibits broad humps, perform a gradient column rinse.<\/p>\n

Rinsing solution A: water for chromatography R.<\/p>\n

Rinsing solution B: acetonitrile for chromatography R.<\/p>\n\n\n\n\n\n\n\n\n\n
Time<\/strong>
\n(min)<\/strong><\/td>\n		Mobile phase<\/strong>
\n(per cent V\/V)<\/strong><\/td>\n		Rinsing solution A<\/strong>
\n(per cent V\/V)<\/strong><\/td>\n		Rinsing solution B<\/strong>
\n(per cent V\/V)<\/strong><\/td>\n<\/tr>\n
0 – 4<\/td>\n100 \u2192 0<\/td>\n0 \u2192 50<\/td>\n0 \u2192 50<\/td>\n<\/tr>\n
4 – 9<\/td>\n0<\/td>\n50<\/td>\n50<\/td>\n<\/tr>\n
9 – 14<\/td>\n0<\/td>\n50 \u2192 10<\/td>\n50 \u2192 90<\/td>\n<\/tr>\n
14 – 54<\/td>\n0<\/td>\n10<\/td>\n90<\/td>\n<\/tr>\n
54 – 69<\/td>\n0<\/td>\n10 \u2192 95<\/td>\n90 \u2192 5<\/td>\n<\/tr>\n
69 – 10<\/td>\n0<\/td>\n95<\/td>\n5<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Related substances<\/h3>\n

Liquid chromatography (2.2.29). Prepare the solutions immediately before use or store them at 2-8 \u00b0C for not more than 24 h.<\/p>\n

Solution A: 1.45 g\/L solution of ammonium formate R in water for chromatography R, adjusted to pH 3.5 with formic acid R.<\/p>\n

Test solution: Dissolve 20.0 mg of the substance to be examined in water R and dilute to 100.0 mL with the same solvent.<\/p>\n

Reference solution (a): Dilute 1.0 mL of the test solution to 100.0 mL with, water R. Dilute 1.0 mL of this solution to 10.0 mL with water R.<\/p>\n

Reference solution (b): In order to prepare impurities B and C in situ, dissolve 30 mg of the substance to be examined in 10 mL of a 4.0 g\/L solution of sodium hydroxide R, heat at 70 \u00b0C for 40 min and allow to cool. Dilute 1 mL of the solution to 10 mL with water R.<\/p>\n

Reference solution (c): Dissolve the contents of a vial of pemetrexed impurity mixture CRS (impurities A and D) in 1 mL of water R.<\/p>\n

Column:<\/p>\n

\u2014 size: l = 0.15 m, \u00d8 = 4.6 mm;<\/p>\n

\u2014 stationary phase: octylsilyl silica gel for chromatography R (3.5 \u03bcm).<\/p>\n

Mobile phase:<\/p>\n

\u2014 mobile phase A: acetonitrile R, solution A (5:95 V\/V);<\/p>\n

\u2014 mobile phase B: acetonitrile R, solution A (30:70 V\/V);<\/p>\n\n\n\n\n\n
Time<\/strong>
\n(min)<\/strong><\/td>\n		Mobile phase<\/strong>
\n(per cent V\/V)<\/strong><\/td>\n		Rinsing solution A<\/strong>
\n(per cent V\/V)<\/strong><\/td>\n<\/tr>\n
0 – 3<\/td>\n100<\/td>\n0<\/td>\n<\/tr>\n
3 – 45<\/td>\n100 \u2192 0<\/td>\n0 \u2192 100<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Flow rate: 1.0 mL\/min.<\/p>\n

Detection: Spectrophotometer at 250 nm.<\/p>\n

Injection: 20 \u03bcL.<\/p>\n

Identification of impurities: Use the chromatogram supplied with pemetrexed impurity mixture CRS and the chromatogram obtained with reference solution (c) to identify the peaks due to impurities A and D; use the chromatogram obtained with reference solution (b) to identify the peaks due to impurities B and C.<\/p>\n

Relative retention: With reference to pemetrexed (retention time = about 26 min): impurity A = about 0.82; impurity B = about 0.87; impurity C = about 0.88; impurity D = about 0.90.<\/p>\n

System suitability:<\/p>\n

\u2014 peak-to-valley ratio: minimum 1.5, where Hp = height above the baseline of the peak due to impurity B and Hv = height above the baseline of the lowest point of the curve separating this peak from the peak due to impurity C in the chromatogram obtained with reference solution (b);<\/p>\n

\u2014 signal-to-noise ratio: minimum 30 for the principal peak in the chromatogram obtained with reference solution (a).<\/p>\n

Calculation of percentage contents:<\/p>\n

\u2014 correction factor: multiply the peak area of impurity D by 1.5;<\/p>\n

\u2014 for each impurity, use the concentration of pemetrexed disodium heptahydrate in reference solution (a).<\/p>\n

Limits:<\/p>\n

\u2014 impurities A, D: for each impurity, maximum 0.15 per cent;<\/p>\n

\u2014 unspecified impurities: for each impurity, maximum 0.10 per cent;<\/p>\n

\u2014 total: maximum 0.6 per cent;<\/p>\n

\u2014 reporting threshold: 0.05 per cent.<\/p>\n

Water (2.5.12)<\/h3>\n

19.5 per cent to 22.1 per cent, determined on 0.050 g.<\/p>\n

ASSAY<\/h2>\n

Liquid chromatography (2.2.29). Prepare the solutions immediately before use or store them at 2-8 \u00b0C for not more than 24 h.<\/p>\n

Acetate buffer: Mix 1.7 mL of glacial acetic acid R and 900 mL of water for chromatography R, adjust to pH 5.3 with a 760 g\/L solution of sodium hydroxide R in water for chromatography R and dilute to 1000 mL with water for chromatography R.<\/p>\n

Test solution: Dissolve 30.0 mg of the substance to be examined in water R and dilute to 200.0 mL with the same solvent.Reference solution Dissolve 30.0 mg of pemetrexed disodium heptahydrate CRS in water R and dilute to 200.0 mL with the same solvent.<\/p>\n

Column:<\/p>\n

\u2014 size: l = 0.15 m, \u00d8 = 4.6 mm;<\/p>\n

\u2014 stationary phase: octylsilyl silica gel for chromatography R (3.5 \u03bcm);<\/p>\n

\u2014 temperature: 30 \u00b0C.<\/p>\n

Mobile phase: acetonitrile R, acetate buffer (11:89 V\/V).<\/p>\n

Flow rate: 2.0 mL\/min.<\/p>\n

Detection: Spectrophotometer at 285 nm.<\/p>\n

Injection: 20 \u03bcL.<\/p>\n

Run time: Twice the retention time of pemetrexed (retention time = about 3 min).<\/p>\n

Calculate the percentage content of C20<\/sub>H19<\/sub>N5<\/sub>Na2<\/sub>O6<\/sub> taking into account the assigned content of pemetrexed disodium heptahydrate CRS<\/p>\n

IMPURITIES<\/h2>\n

Specified impurities A, D, E.<\/p>\n

Other detectable impurities (the following substances would, if present at a sufficient level, be detected by one or other of the tests in the monograph. They are limited by the general acceptance criterion for other\/unspecified impurities and\/or by the general monograph Substances for pharmaceutical use (2034). It is therefore not necessary to identify these impurities for demonstration of compliance. See also 5.10. Control of impurities in substances for pharmaceutical use) B, C.<\/p>\n

 <\/p>\n

\"Pemetrexed<\/p>\n

A. (2S)-2-[4-[2-(2-amino-1-methyl-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzamido]pentanedioic acid,<\/p>\n

\"Pemetrexed<\/p>\n

B. (2S,2\u2032S)-2,2\u2032-[(45<\/sup>R)-42<\/sup>,52<\/sup> -diamino-44<\/sup>,46<\/sup>,54<\/sup>-trioxo-41<\/sup>,44<\/sup>,46<\/sup>,47<\/sup>,54<\/sup>,57<\/sup>-hexahydro-51<\/sup>H-4(5,5),5(6,5)-bis(pyrrolo[2,3-d]pyrimidina)-1,8(1)-dibenzenaoctaphane-14<\/sup>,84<\/sup>-dicarboxamido]dipentanedioic acid,<\/p>\n

\"Pemetrexed<\/p>\n

C. (2S,2\u2032S)-2,2\u2032-[(4 S)-42<\/sup>,52<\/sup> -diamino-44<\/sup>,46<\/sup>,54<\/sup>-trioxo-41<\/sup>,44<\/sup>,46<\/sup>,47<\/sup>,54<\/sup>,57<\/sup>-hexahydro-51<\/sup>H-4(5,5),5(6,5)-bis(pyrrolo[2,3-d]pyrimidina)-1,8(1)-dibenzenaoctaphane-14<\/sup>,84<\/sup>-dicarboxamido]dipentanedioic acid,<\/p>\n

\"Pemetrexed<\/p>\n

D. (2S)-2-[(4S)-4-[4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzamido]-4-carboxybutanamido]pentanedioic acid,<\/p>\n

\"Pemetrexed<\/p>\n

E. (2R)-2-[4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzamido]pentanedioic<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

(Ph. Eur. monograph 2637) C20H19N5Na2O6,7H2O 597.5 357166-29-1 Action and use Thymidylate synthetase inhibitor; cytostatic. DEFINITION Disodium (2S)-2-[4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzamido]pentanedioate heptahydrate. Content 97.5 per cent to 102.0 per cent (anhydrous substance). CHARACTERS Appearance White or almost white powder. Solubility Freely soluble in water, very slightly soluble in anhydrous ethanol, practically insoluble in methylene chloride. IDENTIFICATION A. Infrared absorption…<\/p>\n","protected":false},"author":4,"featured_media":26238,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[174],"tags":[],"class_list":["post-26222","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicinal-substances"],"acf":[],"_links":{"self":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/26222","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/comments?post=26222"}],"version-history":[{"count":2,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/26222\/revisions"}],"predecessor-version":[{"id":26240,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/26222\/revisions\/26240"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media\/26238"}],"wp:attachment":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media?parent=26222"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/categories?post=26222"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/tags?post=26222"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}